MSD Animal Health Wins 2024 S&P Global Award for Best New Companion Animal Product for injectable formulation of BRAVECTO® (fluralaner)
Parasiticide Treatment for Dogs Offers Only Year-Round Flea and Tick Protection Milton Keynes, U.K., 11th March, 2025 – MSD Animal Health, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), has received the S&P Global Animal Health 2024 Best New Companion Animal Product award for the injectable formulation of BRAVECTO® (fluralaner). It is […]